← EU Feed

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Source Summary

Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026

Advertisement
Read Original Article